pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Collaborating to prevent diabetes. How can we get that message into communities? Digital tools.

Diabetes 111

Diabetes Packaging Communication 111

Pharmaceutical Technology

JANUARY 10, 2023

On November 17, 2022, the FDA approved Provention Bio’s Tzield (teplizumab) , making it the first and only treatment to delay the onset of type 1 diabetes (T1D). Tzield’s approval brings the opportunity to explore how the drug can advance diabetes education, treatment, and management. “We Equity in early-stage testing.

Diabetes 98

Diabetes Immunity Immunization Communication 98

Pharmaceutical Technology

MARCH 28, 2023

Vertex Pharmaceuticals has signed a new non-exclusive licensing agreement with CRISPR Therapeutics to expedite the development of its hypoimmune cell therapies to treat type 1 diabetes (T1D). A Phase I/II study of VCTX211 has been commenced and is currently ongoing. It originated under the partnership of CRISPR Therapeutics and ViaCyte.

Diabetes 94

Diabetes Communication 94

pharmaphorum

NOVEMBER 8, 2022

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. Tighter glucose control is known to reduce the risk of complications of diabetes like cardiovascular disease and nerve damage affecting the eyes and extremities.

Diabetes 64

Diabetes Communication 64

Eye on FDA

JANUARY 26, 2022

According to the letter, the agency noted first of all that the video that was part of the Instagram post stated that Trulicity could “lower A1C along with diet and exercise” but that the Medication Guide specifically states that the drug is used for people with type 2 diabetes. So why did OPDP act upon this Instagram post?

Communication 108

Communication Diabetes 108

PharmD Live

NOVEMBER 12, 2024

In recognition of American Diabetes Month , the growing need for effective, accessible and patient-centered diabetes care is emphasized. Approximately 38 million Americans live with diabetes, a condition requiring multiple medications, lifestyle adjustments and frequent monitoring to prevent serious complications. As the U.S.

Diabetes 52

Diabetes Communication 52

pharmaphorum

JUNE 8, 2021

US healthcare group Carbon Health has made a move into digital care for patients with chronic conditions, buying diabetes-focused startup Steady Health. ” The post Carbon Health buys virtual diabetes clinic firm Steady Health appeared first on.

Diabetes 59

Diabetes Communication 59

Viseven

JANUARY 9, 2023

Imagine this as a patient when you are under extreme duress and walk into a clinic or hospital; clear communication is often not feasible. Compelling and well-enunciated communications are quite rare between patient and doctor. Importance of Quality Patient-Doctor Communication.

Communication 52

Communication Hospitals Clinic Management Diabetes 52

Express Pharma

AUGUST 4, 2023

At Novo Nordisk, we are dedicated to tackling chronic diseases by driving change in diabetes, obesity, rare diseases- haemophilia, growth hormone deficiency, etc., Simplifying diabetes care, awareness around obesity and related complications, CVDs and rare diseases like haemophilia continue to be the focus areas for the Indian market.

Diabetes 98

Diabetes Communication 98

ALiEM - Pharm Pearls

AUGUST 18, 2023

The most common etiology of CN III palsy is ischemia of the nerve fibers secondary to diabetes mellitus or hypertension, which preferentially affects the internal somatic fibers that surround the blood supply. However, the most feared etiology is an intracranial aneurysm, most commonly a posterior communicating artery aneurysm.

Communication 130

Communication Diabetes 130

European Pharmaceutical Review

DECEMBER 15, 2022

At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population.

Diabetes 97

Diabetes Packaging Communication 97

Express Pharma

NOVEMBER 1, 2024

The growing incidence of non-communicable diseases (NCDs) also calls for measures to promote the adoption of preventive health screenings and the adoption of alternative healthcare services dedicated to preventive care and the management or reversal of chronic conditions like diabetes.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Biosimilars Communication Diabetes 105

pharmaphorum

JUNE 28, 2022

Recent data from the Japan Diabetes Clinical Data Management (JDDM) study suggests that average HbA1c levels – a biomarker for blood glucose control – have been creeping up among diabetics, indicating that insulin isn’t being used as effectively as it could be. “Patients are receiving an average of 14.8

Diabetes 52

Diabetes Communication 52

Putting Patients First Blog

FEBRUARY 6, 2025

New Trusted Messengers Campaign Tackles Heart Disease, Diabetes and Obesity February 6, 2025 By: Leah Poffenberger, Senior Manager, Communications Millions of Americans are impacted by heart disease, diabetes, or obesityoften in tandem.

Diabetes 52

Diabetes Communication 52

STAT

JULY 10, 2023

Originally developed for people with type 2 diabetes like Fernandez’s parents, Wegovy — the brand name for one of an expanding class of injectable medicines known as GLP-1 receptor agonists — was helping people lose up to 15% of their body weight. They weren’t, originally, even designed to get into the brain.

Communication 246

Communication Diabetes 246

Pharmacy Times

AUGUST 12, 2024

Many patients are unaware of wound complication, so it is valuable for pharmacists to communicate prevention methods with all patients with diabetes.

Diabetes 40

Diabetes Communication 40

Pharma Pathway

SEPTEMBER 17, 2022

Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Excellent Communication Skill. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Job Profile: . Female Medical Representatives. Company : Cipla.

Communication 88

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 88

Putting Patients First Blog

JUNE 24, 2025

This is especially important for those living with a chronic disease or condition, as heatwaves can exacerbate conditions like respiratory and cardiovascular diseases, diabetes, dementia, renal disease, and musculoskeletal disease, according to the World Health Organization.

Communication 52

Communication Diabetes 52

Pharmafile

JANUARY 18, 2023

Previously-developed automated insulin delivery systems can be a useful tool for type 1 diabetics, however they can be incredibly expensive for the patient, making this technology inaccessible for most who therefore have to rely on manually injecting themselves with their daily insulin doses. read more.

Diabetes 59

Diabetes Communication 59

Pharma Marketing Network

JUNE 27, 2025

This ensures consistent communication without overburdening your team. For example, branded messages for diabetes treatments like Trulicity or Ozempic can be tailored based on recipient demographics, prescribing history, or interests. This improves customer journeys, enhances engagement, and drives more meaningful interactions.

HIPAA 52

HIPAA Communication Diabetes Pharmaceutical Companies 52

Pharmafile

JANUARY 10, 2023

The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England and Wales. It is hoped the device will help them manage their condition more effectively, improving quality of life and reducing risk of long-term health issues. read more.

Diabetes 52

Diabetes Communication 52

Pharmafile

MARCH 24, 2023

US-based biotech company Creative Medical Technology has announced that it has filed for the FDA’s Orphan Drug Designation (ODD) for its treatment for Brittle Type 1 diabetes. read more

Diabetes 52

Diabetes Communication 52

Pharma Marketing Network

APRIL 21, 2025

With increasing pressure from regulatory bodies and rising media costs, pharma marketers are rediscovering the power of personalized communication. Importantly, consistency in tone and branding across all pharma communications boosts credibility. Email offers direct, personalized communication with HCPs and patients.

HIPAA 52

HIPAA Communication Diabetes 52

Pharmafile

JANUARY 20, 2023

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process. read more

Compounding 52

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

NOVEMBER 7, 2024

In an industry as specialized as healthcare, personalized communication can make or break your relationship with HCPs and patients. Here’s a quick look at a successful email campaign in pharma: Objective : Increase awareness about a new diabetes drug. That’s the power of healthcare email marketing.

HIPAA 52

HIPAA Communication Diabetes 52

pharmaphorum

OCTOBER 11, 2022

Asked how he made the shift from working out the structure of proteins and how molecules bind to those proteins, to the founding of pharmaphorum and focusing on the digital space, his answer was clear: communication. Tunnah realised, in fact, that that communicative passion lay within himself and wasn’t satisfied by academic work.

Communication 98

Communication Diabetes Drug Development 98

Pharmafile

DECEMBER 16, 2022

Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and commercialise small molecules which modulate novel G protein-coupled receptor (GPCR) targets associated with diabetes and metabolic diseases. read more.

Diabetes 52

Diabetes Communication 52

Pharmacy Is Right For Me

APRIL 4, 2023

It also improves care coordination and eliminates communication gaps. It involves the training of community paramedics in performing some aspects of medication reconciliation. Any medication changes found during these reviews are communicated to the PCP and community pharmacist. What led you to this career path?

Hospitals 130

Hospitals Communication Medical Records Dosage 130

Pharmafile

FEBRUARY 7, 2023

The drug is already approved in the EU for the treatment of type 2 diabetes as well as chronic kidney disease. AstraZeneca has announced that its drug, Forxiga, has been approved in the EU for the treatment of symptomatic chronic heart failure. This follows an approval from the EMA’s Committee for Medicinal Products for Human Use in December.

Diabetes 105

Diabetes Communication 105

European Pharmaceutical Review

JANUARY 27, 2023

.” “Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients,” commented Leigh Ann Pusey, Executive Vice President of corporate affairs and communications for Lilly.

Communication 105

Communication Diabetes 105

pharmaphorum

OCTOBER 2, 2020

We need as many different layers of communication as we can get to make self-care viable in the future”. Hudson stresses the importance of good communications from pharma and healthcare to improve literacy and trust – but says that the industry still often lacks the ability to truly connect with its customers. Ed Hudson, Create Health.

Communication 111

Communication Diabetes 111

Pharmaceutical Technology

DECEMBER 23, 2022

The latest development comes after Lilly and Sosei Heptares signed a partnership for developing small molecules that modulate new G protein-coupled receptor targets linked to diabetes and metabolic diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Communication 131

Communication Diabetes 131

Pharmaceutical Technology

JUNE 12, 2025

The drugmaker’s flagship drug semaglutide, known under the brand names Wegovy and Ozempic for obesity and type 2 diabetes treatment respectively, targets the glucagon-like peptide-1 receptor (GLP-1R), a key component of the incretin system. Give your business an edge with our leading industry insights.

Diabetes 59

Diabetes Compounding Communication Hospitals 59

Board Vitals - Pharmacist

DECEMBER 1, 2023

Patient Communication Some call it creating “happy patients,” others want to improve “patient experience,” and yet others mention “patient satisfaction.” Regardless of the term you use, communicating with patients in order to improve their care, compliance, and satisfaction is a worthy goal. It’s a matter of good health. “My

Communication 98

Communication Documentation Diabetes 98

Pharmaceutical Technology

JUNE 6, 2025

Find out more RTU cartridges are essential for storing glucagon-like peptide-1 drugs, biologics, insulin and hormone therapies used for treating diabetes, obesity and other immunological conditions. It will further extend the site’s manufacturing capabilities for high-value solutions.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes Hospitals 52

pharmaphorum

APRIL 28, 2022

Abbott has joined forces with two other companies to bring an automated insulin delivery (AID) system to people with diabetes in Europe that will monitor blood glucose levels and deliver insulin automatically. Adding Abbott to the alliance closes the circle, moving close to an entirely automated system for people with diabetes.

Diabetes 52

Diabetes Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105